Загрузка...
Can broadly neutralizing monoclonal antibodies lead us to a hepatitis C virus vaccine?
While licensed vaccines elicit protective antibody responses against a variety of viral infections, an effective vaccine for hepatitis C virus (HCV) has remained elusive. The extraordinary genetic diversity of HCV and the ability of the virus to evade the immune response have hindered vaccine develo...
Сохранить в:
| Опубликовано в: : | Trends Microbiol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421862/ https://ncbi.nlm.nih.gov/pubmed/29703495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tim.2018.04.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|